Core Viewpoint - The article discusses the potential investment opportunity in Rivian, suggesting it could be a value stock with significant growth potential as it prepares to launch affordable electric vehicle models by 2026 [2][9]. Group 1: Tesla's Market Position - Tesla has been a remarkable investment, with shares increasing over 34,000% since 2010, largely due to its ability to deliver affordable electric vehicles [3]. - Approximately 70% of U.S. car buyers prefer to spend less than $50,000 on their next vehicle, which has influenced Tesla's strategy to offer lower-cost options [4]. - The introduction of the Model 3 in 2017 and the Model Y in 2020 has been pivotal, with over 90% of Tesla's sales coming from these two models [5]. Group 2: Rivian's Growth Potential - Rivian, which went public in 2021 with a market cap of $150 billion, has seen its valuation drop to below $20 billion, presenting a potential buying opportunity for value investors [8]. - The company has faced challenges, including regulatory headwinds and a lack of new model introductions, which have contributed to its declining stock price [9]. - Rivian plans to launch three new affordable SUV models (R2, R3, and R3X) in 2026, which could lead to a significant sales ramp-up, potentially outpacing Tesla's earlier launches [10][11].

ETF Market Overview - ETF market net inflows have topped $923 billion this year, on track for another trillion dollar year [1][2] - ETFs are popular due to transparency, tax efficiency, and surpassing other investment vehicles [2] Top ETF Inflows - Top ETF inflows included VGT (Vanguard Information Technology Index Fund), GLD (a gold ETF), and XLF [3] - Investors are interested in gold and technology [4] Crossmark Investments' ETFs - Crossmark launched two ETFs two months ago: large cap growth (CLCG) and large cap value (CLCV) [5] - Investors are moving money from SMAs and mutual funds into ETFs [6] CLCG (Crossmark Large Growth ETF) - CLCG invests in growth stocks with reasonable valuations (price to free cash flow) and high returns on equity profitability [8] - Holdings include some of the "mag seven" and financial stocks [9] CLCV (Crossmark Large Value ETF) - CLCV provides exposure to value stocks, particularly financials, banks, and financial service companies [10][11] - Banks are considered cheap relative to the market, benefiting from deregulation [11] Investment Strategy - A balanced portfolio is recommended, and investors should consider the value ETF to complement overweight growth positions [10][12] - Some investors are allocating 50% to each of the growth and value ETFs [13] - Value is cheap relative to growth, offering a risk-reward opportunity [13]

Group 1 - The First Trust Long/Short Equity ETF (FTLS) was recommended as a Buy, generating a 7.50% return compared to the S&P 500's 10.54% return since the recommendation [1] - The analyst, known as The Barnacle, emphasizes the importance of quantitative analysis and mathematics in investment decisions, often disregarding sell-side analysis [1] - The focus has shifted towards ETF strategies that may outperform the market or provide better risk protection, moving away from individual stock analysis [1] Group 2 - The analyst holds a beneficial long position in FTLS and NVDA through various financial instruments [2] - The article reflects the analyst's personal opinions and is not influenced by compensation from any company mentioned [2]

Group 1 - The stock market is currently expensive, prompting a focus on value stocks as potential investment opportunities [1] - There are many catalyst-driven names that trade at great value, which can be uncovered through careful analysis [1] Group 2 - Gary Alexander has extensive experience in covering technology companies and has been a contributor on Seeking Alpha since 2017 [2] - His insights are widely recognized, with his articles being syndicated to popular trading apps like Robinhood [2]

Value stocks cater to investors who want to buy reliable companies with a decent margin of safety. Instead of buying high-flying growth stocks that can crash and burn if the economy goes through a recession, value stocks can hold their ground during uncertainty. However, buying and holding value stocks still makes it possible to become rich. Their gains may not look exciting compared to the hottest AI stocks, but if you give them time to grow, some value stocks can outperform most of the stock market. Dis ...

Core Insights - The article discusses the performance of value stocks, particularly those that pay dividends, highlighting their historical outperformance compared to growth stocks [2][4]. Value Stocks Performance - Value stocks, defined by low price-to-book ratios, have outperformed growth stocks by an average of 2.5% annually since 1926 [2]. - The trend of value stocks outperforming growth stocks was disrupted during the global financial crisis from 2007 to 2020, but value stocks regained some traction in 2020 before losing ground again in late 2022 [2]. Investment Strategy - Joseph H. Davis from Vanguard emphasizes the importance of broad diversification and focusing on undervalued stocks to mitigate risks associated with market transformations, such as those driven by artificial intelligence [3]. Methodology for Stock Selection - The article utilizes Insider Monkey's Q2 2025 database to identify dividend stocks with forward P/E ratios below 25 as of September 26, ranking them based on hedge fund interest [6]. Company Highlights - **Eli Lilly and Company (NYSE: LLY)** - Forward P/E as of September 26: 23.70 - Major revenue drivers include Mounjaro, Zepbound, and Verzenio, which contributed to 65% of Q2 revenue of $15.6 billion, with growth rates between 12% and 172% [9]. - R&D expenses increased by 23% year-over-year to $3.3 billion, representing over 21% of revenue [10]. - The company has raised dividends for 11 consecutive years, currently offering $1.50 per share with a yield of 0.83% [11]. - **Abbott Laboratories (NYSE: ABT)** - Forward P/E as of September 26: 23.42 - Declared a quarterly dividend of $0.59 per share, maintaining a 53-year streak of dividend increases, with a yield of 1.77% [13]. - The FreeStyle Libre glucose monitoring system has become a significant growth driver despite a decline in COVID-19 test sales [14]. - **Illinois Tool Works Inc. (NYSE: ITW)** - Forward P/E as of September 26: 22.47 - Focuses on efficiency and customer-driven innovation, with a strategy that emphasizes operational improvements and disciplined portfolio management [15][16]. - Announced a 7.3% increase in its quarterly dividend to $1.61 per share, extending its dividend growth streak to 53 years, with a yield of 2.47% [17].

Group 1 - The Conservative Income Portfolio focuses on value stocks with high margins of safety and aims to reduce volatility through well-priced options [1][2] - The Enhanced Equity Income Solutions Portfolio is designed to generate yields of 7-9% while minimizing volatility [1] - The Covered Calls Portfolio aims for lower volatility income investing with an emphasis on capital preservation [1][2] Group 2 - Trapping Value is a team of analysts with over 40 years of combined experience in generating options income and capital preservation [2] - The investing group operates the Conservative Income Portfolio in partnership with Preferred Stock Trader, featuring two income-generating portfolios and a bond ladder [2]

Group 1 - AerCap (AER) has experienced a significant increase of 27% in 2025, outperforming the index despite the general decline of value stocks compared to technology stocks [1] Group 2 - The article highlights the importance of fundamental analysis in identifying investment opportunities that are undervalued and present a favorable risk/reward profile [2] Group 3 - The analyst has a beneficial long position in AerCap shares, indicating confidence in the company's future performance [3] Group 4 - The article does not provide any specific recommendations or advice regarding investment suitability for individual investors [4]

Key Points UnitedHealth has been in a tailspin this year as the company's performance has fallen well short of analyst expectations. The company, however, recently reaffirmed its guidance for the year, suggesting that perhaps there is finally some more stability ahead. 10 stocks we like better than UnitedHealth Group › The problem with trying to buy a stock at its low is that you'll only know whether it has bottomed out after it has done so. When it's in the midst of a sell-off, it's impossible to ...

Group 1 - The current economic environment reflects a 1970s vibe, with the Federal Reserve expected to maintain a hot economy for the next few quarters, raising inflation concerns [1] - The Trump administration is likely to appreciate the Fed's approach, which may influence market dynamics and investor sentiment [1] Group 2 - The article does not provide specific company or industry insights, focusing instead on broader economic trends and investor behavior [2][3][4]